Surgical Decisions for Early Stage, Non–Small Cell Lung Cancer: Which Racially Sensitive Perceptions of Cancer Are Likely to Explain Racial Variation in Surgery?
- 1 March 2003
- journal article
- Published by SAGE Publications in Medical Decision Making
- Vol. 23 (2) , 167-176
- https://doi.org/10.1177/0272989x03251244
Abstract
Objectives. Twenty-three percent of white and 36% of African American patients who suffer from early stage non–small cell lung cancer do not undergo potentially curative surgery. A simple decision model is presented to probe for elements of surgical decision making that could explain decisions against lung cancer surgery and racial variation in these decisions. Methods. A survey of 181 diverse individuals to measure health utility scores for conditions relevant to lung cancer surgery was performed. These scores were inserted into a simple model that calculates quality-adjusted survival related to decisions for and against cancer surgery. Results. The health utility score (HUS) for progressive lung cancer, as determined by a survey using the standard gamble approach, is nearly twice as high in African Americans as whites (0.32 v. 0.18). However, in a model incorporating African American utility data, lung cancer surgery remains heavily favored compared to the no-surgery decision (2.32 v. 0.48 quality-adjusted life years). Sensitivity analysis shows that factors that lead to a belief of cancer “cure” in the absence of surgical intervention are much more important than variations of HUS in directing model results away from surgery. Conclusion. This analysis illustrates that racial differences in quality-of-life ratings of progressive lung cancer as measured by HUS exist but may not explain decisions against surgery as much as other elements of patient care.Keywords
This publication has 29 references indexed in Scilit:
- Patient Preferences Regarding Possible Outcomes of Lung ResectionChest, 2000
- Racial Differences in the Treatment of Early-Stage Lung CancerNew England Journal of Medicine, 1999
- A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinomaCancer, 1999
- Prognostic models of thirty-day mortality and morbidity after major pulmonary resectionThe Journal of Thoracic and Cardiovascular Surgery, 1999
- Racial differences in patients’ perceptions of debilitated health statesJournal of General Internal Medicine, 1999
- Postoperative radiotherapy for radically resected N2 non-small-cell lung cancer (NSCLC): randomised clinical study 1988–1992Lung Cancer, 1996
- “Adjuvant” external radiation of the mediastinum in radically resected non-small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Survival Analysis of Untreated Patients With Non-Small-Cell Lung CancerChest, 1994
- Adjuvant Chemotherapy With Cyclophosphamide, Doxorubicin, and Cisplatin in Patients With Completely Resected Stage I Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993